文献速递腹部技术与安全CT

肝脏CT图像质量:低剂量深度学习去噪与标准剂量基于模型的迭代重建比较

Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions.
PubMed 文献 · Eur Radiol · 2021-11-25

这项回顾性研究纳入80例肝脏局灶性病变患者的CT图像,比较33.3%剂量低剂量肝脏CT使用深度学习去噪与100%剂量标准剂量CT使用基于模型的迭代重建的图像质量和显著性(恶性和癌前)肝脏病变可检测性;低剂量CT在总体图像质量和病变可检测性方面非劣效于标准剂量CT,且辐射剂量降低67%。

要点

  • 低剂量肝脏CT使用深度学习去噪在降低67%辐射剂量下,总体图像质量非劣效于标准剂量CT使用基于模型的迭代重建。
  • 低剂量CT的病变对比噪声比显著优于标准剂量CT,但定性图像质量评分显著低于标准剂量CT。
  • 低剂量CT对恶性和癌前肝脏病变的可检测性非劣效于标准剂量CT。

核心结论

  • 使用深度学习去噪的低剂量肝脏CT在辐射剂量降低67%的情况下,总体图像质量和病变可检测性非劣效于使用基于模型的迭代重建的标准剂量CT。

研究设计与样本

  • 回顾性研究,纳入80例有肝脏局灶性病变患者的CT图像;低剂量CT为33.3%剂量,标准剂量CT为100%剂量;图像质量非劣效界值为5分制评分差异-0.5分,病变可检测性非劣效界值为品质因数差异95%CI下限不低于-0.1,采用jackknife替代自由响应ROC分析比较64对CT。

诊断标准与关键数值

  • 总体图像质量评分低剂量CT为3.77±0.38,标准剂量CT为3.94±0.34,差异为-0.17(95%CI:-0.21至-0.12),未跨越预设非劣效界值-0.5;病变检测品质因数低剂量CT为0.859,标准剂量CT为0.878,差异为-0.019(95%CI:-0.058至0.021),显示非劣效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the overall image quality and detectability of significant (malignant and pre-malignant) liver lesions of low-dose liver CT (LDCT, 33.3% dose) using deep learning denoising (DLD) to standard-dose CT (SDCT, 100% dose) using model-based iterative reconstruction (MBIR).

METHODS: In this retrospective study, CT images of 80 patients with hepatic focal lesions were included. For noninferiority analysis of overall image quality, a margin of - 0.5 points (scored in a 5-point scale) for the difference between scan protocols was pre-defined. Other quantitative or qualitative image quality assessments were performed. Additionally, detectability of significant liver lesions was compared, with 64 pairs of CT, using the jackknife alternative free-response ROC analysis, with noninferior margin defined by the lower limit of 95% confidence interval (CI) of the difference of figure-of-merit less than - 0.1.

RESULTS: The mean overall image quality scores with LDCT and SDCT were 3.77 ± 0.38 and 3.94 ± 0.34, respectively, demonstrating a difference of - 0.17 (95% CI: - 0.21 to - 0.12), which did not cross the predefined noninferiority margin of - 0.5. Furthermore, LDCT showed significantly superior quantitative results of liver lesion contrast to noise ratio (p < 0.05). However, although LDCT scored higher than the average score in qualitative image quality assessments, they were significantly lower than those of SDCT (p < 0.05). Figure-of-merit for lesion detection was 0.859 for LDCT and 0.878 for SDCT, showing noninferiority (difference: - 0.019, 95% CI: - 0.058 to 0.021).

CONCLUSION: LDCT using DLD with 67% radiation dose reduction showed non-inferior overall image quality and lesion detectability, compared to SDCT.

KEY POINTS: • Low-dose liver CT using deep learning denoising (DLD), at 67% dose reduction, provided non-inferior overall image quality compared to standard-dose CT using model-based iterative reconstruction (MBIR). • Low-dose CT using DLD showed significantly less noise and higher CNR lesion to liver than standard-dose CT using MBIR and demonstrated at least average image quality score among all readers, albeit with lower scores than standard-dose CT using MBIR. • Low-dose liver CT showed noninferior detectability for malignant and pre-malignant liver lesions, compared to standard-dose CT.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park, Yoon, Joo, et al. Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions. Eur Radiol. 2021. PMID: 34821967. doi:10.1007/s00330-021-08380-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。